|
1
|
Figlin R, Sternberg C and Wood CG: Novel
agents and approaches for advanced renal cell carcinoma. J Urol.
188:707–715. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garcia JA and Rini BI: Recent progress in
the management of advanced renal cell carcinoma. CA Cancer J Clin.
57:112–125. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Finn OJ: Human tumor antigens,
immunosurveillance, and cancer vaccines. Immunol Res. 36:73–82.
2006. View Article : Google Scholar
|
|
4
|
Zou W: Regulatory T cells, tumour immunity
and immunotherapy. Nat Rev Immunol. 6:295–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Banerjee A, Vasanthakumar A and
Grigoriadis G: Modulating T regulatory cells in cancer: how close
are we? Immunol Cell Biol. 91:340–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono
M: Regulatory T cells and immune tolerance. Cell. 133:775–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mougiakakos D, Choudhury A, Lladser A,
Kiessling R and Johansson CC: Regulatory T cells in cancer. Adv
Cancer Res. 107:57–117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao X: Regulatory T cells and immune
tolerance to tumors. Immunol Res. 46:79–93. 2010. View Article : Google Scholar
|
|
9
|
Zhou L, Chong MM and Littman DR:
Plasticity of CD4+ T cell lineage differentiation.
Immunity. 30:646–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vojdani A: A potential link between
environmental triggers and autoimmunity. Autoimmune Dis.
2014:4372312014.PubMed/NCBI
|
|
11
|
Lang F, Linlin M, Ye T and Yuhai Z:
Alterations of dendritic cell subsets and TH1/TH2 cytokines in the
peripheral circulation of patients with superficial transitional
cell carcinoma of the bladder. J Clin Lab Anal. 26:365–371. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gaur P, Qadir GA, Upadhyay S, Singh AK,
Shukla NK and Das SN: Skewed immunological balance between Th17
(CD4(+)IL17A (+)) and Treg (CD4
(+)CD25 (+)FOXP3 (+)) cells in
human oral squamous cell carcinoma. Cell Oncol (Dordr). 35:335–343.
2012. View Article : Google Scholar
|
|
13
|
Bedke J1, Pritsch M, Buse S, et al:
Prognostic stratification of localized renal cell carcinoma by
tumor size. J Urol. 180:62–67. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edge SB, Byrd DR, Compton CC, et al:
Kidney. AJCC Cancer Staging Manual. 7th edition. Springer; New
York, NY: pp. 479–89. 2010
|
|
15
|
Al-Aynati M, Chen V, Salama S, et al:
Interobserver and intraobserver variability using the Fuhrman
grading system for renal cell carcinoma. Arch Pathol Lab Med.
127:593–596. 2003.PubMed/NCBI
|
|
16
|
Hsu SM, Raine L and Fanger H: Use of
avidin-biotin-peroxidase complex (ABC) in immunoperoxidase
techniques: a comparison between ABC and unlabeled antibody (PAP)
procedures. Journal Histochem Cytochem. 29:577–580. 1981.
View Article : Google Scholar
|
|
17
|
Ruffell B, DeNardo DG, Affara NI and
Coussens LM: Lymphocytes in cancer development: polarization
towards pro-tumor immunity. Cytokine Growth Factor Rev. 21:3–10.
2010. View Article : Google Scholar :
|
|
18
|
Agarwal A, Agrawal U, Verma S, Mohanty NK
and Saxena S: Serum Th1 and Th2 cytokine balance in patients of
superficial transitional cell carcinoma of bladder pre- and
post-intravesical combination immunotherapy. Immunopharmacol
Immunotoxicol. 32:348–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herber DL, Nagaraj S, Djeu JY and
Gabrilovich DI: Mechanism and therapeutic reversal of immune
suppression in cancer. Cancer Res. 67:5067–5069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishimura T, Iwakabe K, Sekimoto M, et al:
Distinct role of antigen-specific T helper type 1 (Th1) and Th2
cells in tumor eradication in vivo. J Exp Med. 190:617–627. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ladoire S, Arnould L, Apetoh L, et al:
Pathologic complete response to neoadjuvant chemotherapy of breast
carcinoma is associated with the disappearance of
tumor-infiltrating foxp3+ regulatory T cells. Clin
Cancer Res. 14:2413–2420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Xu K, Wu J, et al: The changes of
Th17 cells and the related cytokines in the progression of human
colorectal cancers. BMC Cancer. 12:4182012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizukami Y, Kono K, Kawaguchi Y, et al:
Localisation pattern of Foxp3+ regulatory T cells is
associated with clinical behaviour in gastric cancer. Br J Cancer.
98:148–153. 2008. View Article : Google Scholar
|
|
24
|
Liotta F, Gacci M, Frosali F, et al:
Frequency of regulatory T cells in peripheral blood and in
tumour-infiltrating lymphocytes correlates with poor prognosis in
renal cell carcinoma. BJU Int. 107:1500–1506. 2011. View Article : Google Scholar
|
|
25
|
Svensson H, Olofsson V, Lundin S, et al:
Accumulation of CCR4(+)CTLA-4
FOXP3(+)CD25(hi) regulatory T cells in colon
adenocarcinomas correlate to reduced activation of conventional T
cells. PloS One. 7:e306952012. View Article : Google Scholar
|
|
26
|
Chen KJ, Lin SZ, Zhou L, et al: Selective
recruitment of regulatory T cell through CCR6-CCL20 in
hepatocellular carcinoma fosters tumor progression and predicts
poor prognosis. PloS One. 6:e246712011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wilke CM, Bishop K, Fox D and Zou W:
Deciphering the role of Th17 cells in human disease. Trends
Immunol. 2:603–611. 2011. View Article : Google Scholar
|
|
28
|
Zamarron BF and Chen W: Dual roles of
immune cells and their factors in cancer development and
progression. Int J Biol Sci. 7:651–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kryczek I, Wei S, Zou L, et al: Cutting
edge: Th17 and regulatory T cell dynamics and the regulation by
IL-2 in the tumor microenvironment. J Immunol. 178:6730–6733. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyahara Y, Odunsi K, Chen W, Peng G,
Matsuzaki J and Wang RF: Generation and regulation of human
CD4+ IL-17-producing T cells in ovarian cancer. Proc
Natl Acad Sci USA. 105:15505–15510. 2008. View Article : Google Scholar
|
|
31
|
Sfanos KS, Bruno TC, Maris CH, et al:
Phenotypic analysis of prostate-infiltrating lymphocytes reveals
TH17 and Treg skewing. Clin Cancer Res. 14:3254–3261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
